May 22, 2025 New FDA-Approved Topical Foam for Scalp Psoriasis The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas.. Conexiant
Pharmacologic Toll-like Receptor 4 Inhibition Ameliorates Early Astrogliosis Improving Neurocognitive Outcomes Following Traumatic Brain Injury
Slowing of Junctional Escape Rhythm Following Atrioventricular Node Ablation in a Porcine Model of Complete AV Block
June 10, 2024 How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life The ASCO Post